By J. Edward Moreno ( September 9, 2021, 4:05 PM EDT) -- Disgraced former pharmaceutical executive Martin Shkreli will face an in-person bench trial in mid-December in the Federal Trade Commission's case accusing him and the company he founded, Vyera Pharmaceuticals LLC, of monopolizing the market for a lifesaving drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.